ProteinuriaNCT00912834
Study of Prevalence of Proteinuria, Urinary Tract Infection or Hematuria in Athletes
An observational study of Proteinuria, run by Far Eastern Memorial Hospital.
Trial summary
To understand the urine analysis of athletes Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Proteinuria
- How many people
- 300 participants
- Where
- No sites listed yet
- Study dates
- Dec 2008to Nov 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: In some types exercise, including basketball, swimming, tract \& field, tennis, football athletes, we make a study analysis of their urine data to find any abnormality such as microhematuria, proteinuria or pyuria.
Who may be able to join
- proteinuria, hematuria, pyuria
Who cannot join
- bacteriuria
About this study
Official title: Urine Analysis in Different Types of Athletes
To understand the urine analysis of athletes
Read the detailed description
there maybe some genitourinary problem related to athletes, such as proteinuria, hematuria, scrotal pain, STD, etc. To explore these problems and give adequate management for them not only improved athletes' health, but also it can do their best in their exercise performance.
- Conditions
- Proteinuria
- Keywords
- hematuria, urinary tract infection
- Medical subject headings
- Proteinuria, Hematuria, Urinary Tract Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | tract and field athletes | |
| 2 | swimming athletes | |
| 3 | tennis athletes | |
| 4 | football athletes | |
| 5 | basketball athletes | |
| 6 | Badminton athletes | |
| 7 | control group |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2009 (estimated)
- Study startDec 2008
- Primary completionMay 2009 (estimated)
- Study completionNov 2009 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ProteinuriaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 300 participants (actual)
Sponsor and investigators
- Lead sponsor
- Far Eastern Memorial Hospital
- Sponsor type
- University, hospital or other
- Investigators
- Chung Yin Wu, MD, Study chair, Chung Yin Wu
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00912834
- Sponsor's protocol ID
- 97088
- Status last verified
- Jun 2009
- First submitted
- 2 Jun 2009
- Last updated
- 23 Sep 2009
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Urine Analysis in Different Types of Athletes
- ClinicalTrials.gov ID
- NCT00912834
- Acronym / sponsor ID
- 97088
- Conditions
- Proteinuria
- Keywords
- hematuria, urinary tract infection
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (actual)
- Lead sponsor
- Far Eastern Memorial HospitalUniversity, hospital or other
- Study start
- Dec 2008
- Primary completion
- May 2009 (estimated)
- Study completion
- Nov 2009 (estimated)
- First posted
- 3 Jun 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To understand the urine analysis of athletes
Detailed description
there maybe some genitourinary problem related to athletes, such as proteinuria, hematuria, scrotal pain, STD, etc. To explore these problems and give adequate management for them not only improved athletes' health, but also it can do their best in their exercise performance.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
- Number of arms
- 7
| Arm | Type | Receives |
|---|---|---|
| 1 | – | –tract and field athletes |
| 2 | – | –swimming athletes |
| 3 | – | –tennis athletes |
| 4 | – | –football athletes |
| 5 | – | –basketball athletes |
| 6 | – | –Badminton athletes |
| 7 | – | –control group |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- In some types exercise, including basketball, swimming, tract \& field, tennis, football athletes, we make a study analysis of their urine data to find any abnormality such as microhematuria, proteinuria or pyuria.
Key inclusion criteria (1 listed)
- proteinuria, hematuria, pyuria
Key exclusion criteria (1 listed)
- bacteriuria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2009.
Related trials for Proteinuria
RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
C3G
RecruitingObservational study
Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease (ADPKD
RecruitingPhase 3
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
IgA Nephropathy (IgAN)
RecruitingPhase 2
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Focal Segmental Glomerulosclerosis, Minimal Change Disease
RecruitingPhase 2
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
IgA Nephropathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chung Yin Wu, MD study chair
Chung Yin Wu
Questions about this trial
What is this clinical trial studying?
An observational study of Proteinuria, run by Far Eastern Memorial Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Sep 2009. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2009; AzTrials last refreshed its copy on 8 Nov 2026.